Gait ataxia is the central clinical manifestation in VWM patients37 and VWM mice.16 Our oligodendrocyte-specific Eif2b5 mutant mouse line exhibits this phenotype along with several neuropathological and molecular characteristics observed in VWM models. This evidence concerns the gene EIF2B5 and Gait ataxia.